UPC_APP_45044/2024

The Court of Appeal rejected Meril's requests to expedite three appeals (concerning revocation of EP 3 646 825) at Edwards Lifesciences' expense, finding that the potential risk of an injunction being granted in pending infringement proceedings did not justify expedition.